Immediate Impact
2 by Nobel laureates 61 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of D.H. Lee being referenced
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆
2021 Standout
1400P Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLC
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| D.H. Lee | 253 | 110 | 26 | 142 | 16 | 369 | |
| Nausicaa Malissen | 191 | 126 | 30 | 72 | 25 | 340 | |
| Edwin A. Basak | 308 | 90 | 43 | 119 | 18 | 384 | |
| Esmée P. Hoefsmit | 182 | 92 | 30 | 119 | 14 | 339 | |
| George Mo | 158 | 48 | 12 | 79 | 17 | 318 | |
| R. Mondéjar | 211 | 65 | 21 | 50 | 23 | 364 | |
| Aroop Mangalik | 228 | 135 | 16 | 45 | 13 | 392 | |
| Andrea D. Chapman | 164 | 174 | 26 | 81 | 20 | 359 | |
| Jean-François Emile | 126 | 143 | 19 | 110 | 11 | 348 | |
| Yuji Hirami | 217 | 160 | 20 | 142 | 21 | 395 | |
| Konstantinos Rounis | 216 | 96 | 20 | 42 | 22 | 324 |
All Works
Loading papers...